Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;19(4):271.
doi: 10.1038/s41581-023-00690-4.

Use of convalescent plasma in the treatment of COVID-19

Michael J Joyner  1 , Nigel Paneth  2 , Arturo Casadevall  3
Affiliations
Comment

Use of convalescent plasma in the treatment of COVID-19

Michael J Joyner et al. Nat Rev Nephrol. 2023 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

M.J.J. has received a research grant from Octapharma to support the US Convalescent Plasma Program. The other authors declare no competing interests.

Comment in

Comment on

  • Therapeutic advances in COVID-19.
    Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise ME, Leaf DE. Murakami N, et al. Nat Rev Nephrol. 2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17. Nat Rev Nephrol. 2023. PMID: 36253508 Free PMC article. Review.

References

    1. Murakami N, et al. Therapeutic advances in COVID-19. Nat. Rev. Nephrol. 2023;19:38–52. doi: 10.1038/s41581-022-00642-4. - DOI - PMC - PubMed
    1. Libster R, et al. Early high-titer plasma therapy to prevent severe COVID-19 in older adults. N. Engl. J. Med. 2021;384:610–618. doi: 10.1056/NEJMoa2033700. - DOI - PMC - PubMed
    1. Sullivan DJ, et al. Early outpatient treatment for COVID-19 with convalescent plasma. N. Engl. J. Med. 2022;386:1700–1711. doi: 10.1056/NEJMoa2119657. - DOI - PMC - PubMed
    1. Alemany A, et al. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial. Lancet Respir Med. 2022;10:278–288. doi: 10.1016/S2213-2600(21)00545-2. - DOI - PMC - PubMed
    1. Korley FK, Durkalski-Mauldin V, Callaway CW. Convalescent plasma for outpatients with COVID-19. Reply. N. Engl. J. Med. 2021;385:2206–2207. - PMC - PubMed